GC Green Cross Begins First Administration of "Hunterase ICV" in Russia
Expanding Treatment Access Through Collaboration With Local Medical Professionals
GC Green Cross announced on December 3 that its Hunter syndrome (mucopolysaccharidosis type II) treatment, "Hunterase ICV" (ingredient: idursulfase beta), has been administered for the first time in Russia.
This administration was carried out through a program by the "Krug Dobra" Foundation, which provides medical support to vulnerable children. The treatment was given to a pediatric patient in the Astrakhan region at the Russian Children's Clinical Hospital (RCCH). To strengthen treatment capabilities, RCCH also provided both practical and theoretical training to medical staff from Astrakhan.
Hunterase ICV is the world's only Hunter syndrome treatment that delivers the drug directly into the brain ventricles via a device implanted in the head. This therapy reaches the patient's cerebral blood vessels and central nervous system cells, alleviating symptoms caused by central nervous system damage, such as cognitive decline and delayed psychomotor development.
Dr. Dmitry Alexandrovich Reshchikov, a neurosurgeon at RCCH who performed the first administration, stated, "This administration will be an important turning point in the treatment of patients with severe Hunter syndrome," adding, "We expect Hunterase ICV to help improve central nervous system function."
A representative from GC Green Cross commented, "Access to innovative treatments is expanding through international cooperation," and added, "We will continue our efforts to improve the treatment environment for Hunter syndrome patients."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, GC Green Cross plans to work with its Russian partner, Nanolek, to further expand treatment access for patients with severe Hunter syndrome.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.